Though we’re well into the winter season, Lilly Pulitzer always finds a way to get us excited for spring and summer. The beloved brand’s Sunshine Sale is back once again to kick off the new year with ...

Gary Cohn, 72, formerly of Philadelphia, an Inquirer alum who went on to win a Pulitzer Prize at the Baltimore Sun during a decades-long career devoted to investigative reporting, died Monday, Dec. 23 ...

In the time since, though, some analysts have said the reaction is overblown, particularly for weight-loss drugmakers like Wegovy, and Ozempic maker Novo Nordisk and Zepbound maker Eli Lilly.

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks. In his second appearance on Squawk on the Street after the Fed's interest ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...

However, Best Buy has just suddenly launched a Doorbuster sale which takes $350 off the price of the S24 Ultra with 256GB storage, taking the total down to $949.99. This price is for the Titanium ...

which can be used for future exhibitions and sale to the public and private collectors, according to the news release. After Zuzek's death in 2011, Lilly Pulitzer said in an interview that the ...

Eli Lilly announced FDA approval of Zepbound as the first prescription medicine for adults with moderate-to-severe obstructive sleep apnea. In addition, adults on Zepbound lost an average of 45 ...

Eli Lilly sells one of the most sought-after types of drugs today: weight loss drugs. The company’s Zepbound and Mounjaro have brought in blockbuster revenue, and more growth could be on the ...

Sleep apnea, a sleep disorder typically managed with a medical device that aids in breathing, now has its first FDA-approved drug therapy, an Eli Lilly medicine initially developed as a treatment ...

Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug Administration (FDA) as the first prescription drug to help alleviate moderate ...